India IVF Secures $1.25 Million in Pre-Series A Funding from Tomorrow Capital

November 2024 – India IVF, a trailblazing, tech-enabled fertility platform founded in 2014 by Dr. Richika Sahay and Dr. Somendra Shukla, has secured $1.25 million in pre-Series A funding from Tomorrow Capital. This strategic investment marks India IVF’s first external funding round and comes after nearly a decade of successful, profitable operations across its five centers in North India, including locations in Delhi NCR and Srinagar. Tomorrow Capital, a $100 million venture fund dedicated to transformative early-stage consumer healthcare businesses, chose India IVF as part of its commitment to expanding healthcare access in underserved markets.

The newly secured funding will enable India IVF to expand its network across North India, enhancing access to advanced fertility solutions for communities with limited options. The company, recognized as India’s first tech-enabled fertility platform, provides comprehensive, 360-degree fertility care through a robust combination of innovative technology and a team of expert fertility specialists. Tomorrow Capital’s backing will help India IVF address critical gaps in fertility care access, allowing the platform to offer quality fertility solutions in underrepresented regions.

This investment aligns with Tomorrow Capital’s mission to support high-impact healthcare ventures, demonstrated by their recent investments in VitusCare and IndiShreshtha, which also focus on consumer health and well-being.

Rahul Saha, Senior Principal at Tomorrow Capital, expressed confidence in India IVF’s unique approach to fertility care. “India IVF has shown significant growth and a deep understanding of the specific fertility challenges that many Indian couples face. With their tech-enabled, patient-focused model, they provide high-quality, personalized care that addresses the emotional and societal stigmas often associated with fertility treatment,” said Saha. “Tomorrow Capital is committed to ventures that create meaningful impact, and we’re proud to support India IVF’s mission to deliver essential fertility care to underserved areas in India. We believe their innovative approach will set new standards in India’s fertility sector.”

India IVF co-founder and CEO, Dr. Somendra Shukla, highlighted the transformative potential of this partnership, saying, “This partnership will enable us to expand our network and make advanced fertility solutions accessible to more communities. We’re dedicated to positively impacting families nationwide and establishing India IVF as a trusted national brand.”

Dr. Richika Sahay, Co-Founder and Medical Director of India IVF, emphasized the platform’s commitment to addressing the fertility care gap in India. “Approximately 30 million couples in India face infertility challenges, yet only about 10% receive proper treatment due to limited access to fertility care,” Dr. Sahay noted. “Our mission is to leverage technology and innovation to deliver high-quality, affordable, and empathetic fertility care for all. With Tomorrow Capital’s support, we are well-positioned to expand access to fertility solutions throughout North India.”

With Tomorrow Capital’s strategic investment, India IVF is primed to make fertility care more accessible and inclusive, particularly in underserved regions. By harnessing technology to deliver patient-centered, high-quality care, India IVF aims to redefine standards in the country’s fertility landscape, supporting countless couples on their paths to parenthood and creating a more inclusive future for fertility care in India.

Tomorrow Capital is a $100 million operating venture fund investing across consumer-focused sectors. With a focus on early-stage investments, Tomorrow Capital partners with entrepreneurs who have strong, differentiated models, aiming to build transformative, sustainable businesses. Leveraging sector expertise, Tomorrow Capital is dedicated to fostering India’s next generation of iconic consumer brands.

Founded by Dr. Richika Sahay and Dr. Somendra Shukla as a bootstrapped single-room residential clinic in Gurgaon, India IVF has grown into a leading fertility provider in North India, with a presence across Noida, Ghaziabad, Delhi, Gurgaon, and Srinagar. Revolutionizing fertility treatment by introducing India’s first tech-enabled fertility and IVF platform, India IVF delivers holistic, 360-degree, end-to-end fertility care. Leveraging state-of-the-art technology and a team of highly qualified medical professionals, the organization is democratizing fertility care and setting new benchmarks in making advanced reproductive services accessible to everyone.

Dr. Richika Sahay, an IVF specialist and gynecological laparoscopic surgeon with over 20 years of experience, has guided the clinic’s clinical growth, developing specialized protocols for complex cases. She has worked with renowned institutions of India such as Fortis , Max, Sir Ganga Ram and AIIMS  bringing a wealth of experience and expertise to India IVF.

Dr. Somendra Shukla, a pediatrician and neonatologist with over 20 years of experience, holds a certification in Healthcare Entrepreneurship from Harvard Business School. His entrepreneurial drive and medical expertise have helped grow India IVF from a single clinic into a recognized national brand, focused on delivering cutting-edge technology and care to regions where such services are scarce.

Focusing not only on IVF and clinical care, but India IVF also provides comprehensive support by offering emotional, social, financial, and psychological assistance through its team of psychologists, counselors, dietitians, yoga and meditation trainers, and financial institutions. India IVF is accredited by the Department of Health, Government of India, PCPNDT, ICMR, and NABH, ensuring the highest standards of care.